Ann: IMU Meets Endpoints in Phase 1b Gastric Cancer Trial, page-114

Jase, such a brave post. Just like to echo the sentiments of the others who have responded.

Always need that jolt to be reminded that investment in promising medical technologies are not primarily about profit, but rather about human health and happiness.

I hope IMU has the key to a major break through in cancer treatment and most importantly that the driving force behind the thrust to determine its final place in cancer treatment is not about profit, but about getting the answers and implementing them, if positive, ASAP.